SCHEMBL30705255

SCHEMBL30705255

COc1cc2c(-c3ncnc(Cl)n3)cn(C)c2cc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 4/20 0.44
IGF1R P08069 1/20 0.41
CDK1 P06493 1/20 0.36
CDK4 P11802 1/20 0.36
CCNB1 P14635 1/20 0.36
CCND1 P24385 1/20 0.36
CDK2 P24941 1/20 0.36
CDK5 Q00535 1/20 0.36
CDK5R1 Q15078 1/20 0.36
RIPK2 O43353 1/20 0.35
EGFR P00533 1/20 0.35
SRC P12931 1/20 0.35
NOD1 Q9Y239 1/20 0.35
EIF2AK3 Q9NZJ5 2/20 0.35
SUV39H2 Q9H5I1 3/20 0.34
SCN9A Q15858 4/20 0.33
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
MTNR1A P48039 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22509235 1.00 GSK3B (0.44) GSK3BIGF1RCDK1CDK4CCNB1
SCHEMBL30705252 0.80 GSK3B (0.49) GSK3BIGF1RCDK5KDM4EALDH1A1
SCHEMBL22509188 0.80 GSK3B (0.49) GSK3BIGF1RCDK5KDM4EALDH1A1
SCHEMBL22509195 0.76 GSK3B (0.44) GSK3BIGF1RCDK1CDK4CCNB1
SCHEMBL30705248 0.76 GSK3B (0.44) GSK3BIGF1RCDK1CDK4CCNB1
SCHEMBL24240371 0.75 GSK3B (0.34) GSK3BIGF1RCDK1CCNB1CDK2
SCHEMBL30705246 0.75 GSK3B (0.46) GSK3BIGF1RCDK1CCNB1CDK2
SCHEMBL22509160 0.75 GSK3B (0.46) GSK3BIGF1RCDK1CCNB1CDK2
SCHEMBL24240392 0.73 CCNT1 (0.36) GSK3BCDK1CCNB1CDK2CDK5
SCHEMBL30705245 0.73 CCNT1 (0.36) GSK3BCDK1CCNB1CDK2CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111747950-B Pyrimidine derivatives for the treatment of cancer 深圳福沃药业有限公司 2024-01-23 CN disclosed